Stevens MF - Search Results

1

Antitumour polycyclic acridines. Part 2. Physicochemical studies on the interactions between DNA and novel polycyclic acridine derivatives.

Giménez-Arnau E, Missailidis S, Stevens MF. Giménez-Arnau E, et al. Among authors: stevens mf. Anticancer Drug Des. 1998 Mar;13(2):125-43. Anticancer Drug Des. 1998. PMID: 9524555

2

Antitumor polycyclic acridines. Part 16. Triplex DNA as a target for DNA-binding polycyclic acridine derivatives.

Missailidis S, Modi C, Trapani V, Laughton CA, Stevens MF. Missailidis S, et al. Among authors: stevens mf. Oncol Res. 2005;15(2):95-105. Oncol Res. 2005. PMID: 16119007

3

Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.

Missailidis S, Stanslas J, Modi C, Ellis MJ, Robins RA, Laughton CA, Stevens MF. Missailidis S, et al. Among authors: stevens mf. Oncol Res. 2002;13(3):175-89. Oncol Res. 2002. PMID: 12549627

4

Antitumour polycyclic acridines. Part 4. Physico-chemical studies on the interactions between DNA and novel tetracyclic acridine derivatives.

Giménez-Arnau E, Missailidis S, Stevens MF. Giménez-Arnau E, et al. Among authors: stevens mf. Anticancer Drug Des. 1998 Jul;13(5):431-51. Anticancer Drug Des. 1998. PMID: 9702209

5

Molecular recognition between a new pentacyclic acridinium salt and DNA sequences investigated by optical spectroscopic techniques, proton nuclear magnetic resonance spectroscopy, and molecular modeling.

Bostock-Smith CE, Giménez-Arnau E, Missailidis S, Laughton CA, Stevens MF, Searle MS. Bostock-Smith CE, et al. Among authors: stevens mf. Biochemistry. 1999 May 25;38(21):6723-31. doi: 10.1021/bi9825807. Biochemistry. 1999. PMID: 10346892

6

Antitumour imidazotetrazines. Part 37. Conjugation of the DNA major-groove alkylating imidazotetrazine mitozolomide to peptide motifs recognizing the minor groove.

Arrowsmith J, Missailidis S, Stevens MF. Arrowsmith J, et al. Among authors: stevens mf. Anticancer Drug Des. 1999 Jun;14(3):205-17. Anticancer Drug Des. 1999. PMID: 10500496

7

Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents.

Cheng MK, Modi C, Cookson JC, Hutchinson I, Heald RA, McCarroll AJ, Missailidis S, Tanious F, Wilson WD, Mergny JL, Laughton CA, Stevens MF. Cheng MK, et al. Among authors: stevens mf. J Med Chem. 2008 Feb 28;51(4):963-75. doi: 10.1021/jm070587t. Epub 2008 Feb 2. J Med Chem. 2008. PMID: 18247546

8

Structural studies on bio-active compounds. Part 21. Acid-promoted debenzylations in antitumour 2,4-diamino-5-[4-(N-alkylbenzylamino)-3-nitrophenyl]-6-ethylp yrimidines.

Griffin RJ, Stevens MF. Griffin RJ, et al. Among authors: stevens mf. Anticancer Drug Des. 1992 Dec;7(6):443-9. Anticancer Drug Des. 1992. PMID: 1285839

9

Structural studies on bioactive compounds. Part 26. Hydrogen bonding in the crystal structure of the N-methylformamide solvate of the immunomodulatory agent 2-amino-5-bromo-6-phenylpyrimidin-4-one (bropirimine): implications for the design of novel anti-tumour strategies.

Stevens MF, Schwalbe CH, Patel N, Gate EN, Bryant PK. Stevens MF, et al. Anticancer Drug Des. 1995 Apr;10(3):203-13. Anticancer Drug Des. 1995. PMID: 7748455

10

Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNA.

Sansom CE, Laughton CA, Neidle S, Schwalbe CH, Stevens MF. Sansom CE, et al. Among authors: stevens mf. Anticancer Drug Des. 1990 Aug;5(3):243-8. Anticancer Drug Des. 1990. PMID: 2400537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters